Biological Activity, Structural Characterization and Crystal Packing of Chromane-Carboxylate Derivatives

Open access

Abstract

We report here the crystal and molecular structure of a new chromane-derivative, namely isopropyl( 2R*,3S*,4S*)-4-(benzo[d]thiazol-2-ylamino)-2-hydroxy-2-ethylchromane-3-carboxylate (I), C21H22N2O4S, which crystallizes as racemate in the space group C2/c. Its structure has been solved using X-ray diffraction data obtained at low temperature (100(2) K). In this compound, the chromane moiety consists of a benzene ring fused with a six-membered heterocyclic ring which adopts a distorted half-chair conformation. The molecules are linked by a combination of O-H∙∙∙N and N-H∙∙∙O hydrogen bonds, resulting in a twodimensional network which helps stabilizing the crystal structure of the compound (I). Dihedral angle between the chromane and benzothiazol rings is 80.6(1)0.

Akhtar T, Hameed S, Al-Masoudi NA, Loddo R, La Colla P (2008) Acta Pharm. 58: 135-149.

Allen FH, Johnson O, Shields GP, Smith BR, Towler M (2004) J. Appl. Cryst. 37: 335-338.

Bernstein J, Davis RE, Shimoni L, Chang NL (1995) Angew. Chem. Int. Ed. Engl. 34: 1555-1573.

Brandenburg K (2001) DIAMOND. Crystal Impact GbR, Bonn, Germany.

Cremer D, Pople JA (1975) J. Am. Chem. Soc. 97: 1354-1362.

Ellis GP, Lockhart IM, Meedernycz D, Schweizer EE (1977) Chromenes, Chromanones and Chromones, edited by GP, Ellis. New York: John Wiley and Sons, Inc.

Ellis GP, Lockhart IM (2007). The Chemistry of Heterocyclic Compounds, hromenes, Chromanones and Chromones 31: edited by G. P. Ellis 1-119. New York: Wiley-VCH.

Farrugia LJ (1999) J. Appl. Cryst. 30: 565. Horton DA, Boume GT, Smythe ML (2003) Chem. Rev.103: 893-930.

Hussain MI, Amir M (1986) J. Indian Chem. Soc. 63: 317-320.

Chenera P, West ML, Finkelstein JA, Dreyer GBJ (1993) J. Org. Chem. 58: 5605-5606.

Choi SJ, Park HJ, Lee SK, Kim SW, Han G, Choo HYP (2006) Bioorg. Med. Chem. 14: 1229-1235.

Jin L, Song B, Zhang G, Xu R, Zhang S, Gao X, Hu D, Yang S (2006) Bioorg. Med. Chem. Lett. 16: 1537-1543.

Koojiman H, Spek AL, Kleijin H, Van Maanen HL, Jastrzelski JT, Van Kozrkowski AP (1984) Acc. Chem. Res. 17: 410-416.

Kwak JH, Kim BH, Jung JK, Kim Y, Cho J, Lee H (2007). Arch. Pharm. Res. 30: 1210-1215.

Lampronti I, Martello D, Bianchi N, Borgatti M, Lambertini E, Piva R, Jabbar S, Shahabuddin Kabir Choudhuri M, Tareq Hassan Khan M, Gambari R (2003) Phytomedicine 10: 300-308.

Lang F, Zewge D, Song ZJ, Biba M, Dormer P, Tschaen D, Volanteb RP, Reiderb PJ (2003) Tetrahedron Lett. 44: 5285-5288.

Ma T, Liu L, Xue H, Li L, Han C, Wang L, Chen Z, Liu G (2008) J. Med. Chem. 51: 1432-1446.

Mortimer CG, Wells G, Crochard JP, Stone EL, Bradshaw TD, Stevens MFG, Westwell AD (2006) J. Med. Chem. 49: 179-185.

Nicolaou KC, Pfefferkorn JA, Roecker AJ, Cao GQ, Barluenga S, Mitchell HJ (2000) J. Am. Chem. Soc. 122: 9939-9953.

O’Brien SE, Browne HL, Bradshaw TD, Westwell AD, Stevens MFG, Laughton CA (2003) Org. Biomol. Chem. 1: 493-497.

Oxford Diffraction (2009). CrysAlisPro. Oxford Diffraction Ltd, Abingdon, Oxfordshire, England.

Pecchio M, Solís PN, López-Pérez JL, Vasquez Y, Rodríguez N, Olmedo D, Correa M, San Feliciano A, Gupta MP (2006) J. Nat. Prod. 69: 410-413.

Prado S, Janin YL, Saint-Joanis B, Brodin P, Michel S, Koch M, Cole ST, Tillequin F, Bost PE (2007) Bioorg. Med. Chem. 15: 2177-2186.

Sheldrick GM (2008) Acta Cryst. A64: 112-122.

Spek AL (2009) Acta Cryst. D65: 148-155.

Svĕtlík J, Prónayová N, Švorc Ľ, Frecer V (2014) Tetrahedron 70: 8354-8360.

Tanaka N, Takaish, Y, Shikishima Y, Nakanishi Y, Bastow K, Lee KH, Honda G, Ito M, Takeda Y, Kodzhimatov OK, Ashurmetov O (2004) J. Nat. Prod. 67: 1870-1875.

Zou YS, Hou AJ, Zhu GF (2005) Chem. Biodivers. 2: 131-138.

Acta Chimica Slovaca

The Journal of Slovak University of Technology in Bratislava

Journal Information

Metrics

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 101 101 19
PDF Downloads 65 65 9